Population
Platelets, including Akt-1 knock-out platelets
Comparison
Akt inhibitors, PI3K inhibitors, 8-bromo-cGMP… vs Untreated or wild-type platelets
Design
Preclinical
Authors
Loading...
Extends the platelet signaling map via Akt-NO-cGMP; leaves open whether pathway inhibition alters thrombosis in vivo.
This study delineates a novel platelet activation pathway involving sequential activation of PI3K, Akt, nitric-oxide synthase 3, sGC, and cGMP-dependent protein kinase.
Stojanović et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: